Bardosi A, Brkovic D, Gabius H J
Institute of Pathology, Academic Hospital of University of Münster, F.R.G.
Anticancer Res. 1991 May-Jun;11(3):1183-8.
The carbohydrate part of cellular glycoconjugates - glycoproteins, glycoproteins, glycolipids and proteoglycans - and specific endogenous sugar receptors, i.e. lectins, can establish a system of biological recognition based on protein-sugar interactions on the cellular and subcellular levels. To gain insight into the role of proteins in this type of interaction, sections of surgically removed tumor specimens of central and peripheral nervous tissue were analyzed glycohistochemically, using biotinylated neoglycoproteins with different sugar part. A specific staining with this type of probe, exposing different sugar moieties as ligands, indicated the presence of sugar receptors in different types of meningiomas, glioblastomas, gangliocytomas, anaplastic and well-differentiated oligodendrogliomas and ependymomas as well as in neurinomas and neurofibromas of peripheral nerves. In comparison to the well-differentiated ependymomas, the anaplastic form of this tumor exhibited a generally higher capacity to specifically bind the neoglycoproteins, containing alpha- or beta-glucosides. Inverse intensity of the glycohistochemical reaction was observed with galactose-6-phosphate-, galactose-beta(1.3)-N-acetylglucosamine-N-acetyl-D-glucosamine- and mannose- (BSA- biotin), respectively, when anaplastic and differentiated oligodendrogliomas were compared with each other. Tumorously dedifferentiated neurons, i.e. in gangliocytomas, showed a changed spectrum of endogenous sugar receptors in comparison to neurons of normal cerebral cortex. Qualitative and quantitative differences of sugar receptors were observed among the distinct subtypes of meningiomas. Receptors for N-acetyl-D-galactosamine were present only in the anaplastic form, while glucuronic acid-specific receptors were only found in the meningotheliomatous meningiomas. Distinctions in binding spectrum of neoglycoproteins suggest the presence of a possible additional subtype of meningiomas, called submalignant meningioma. Analysis of the spectrum of endogenous sugar receptors can serve to distinguish between different cell populations composing a given tumor, as shown in neurofibromas in the cases of Schwann cells and fibroblastoid cells stained with N-acetyl-D-glucosamine-(BSA-biotin). The analysis of expression of endogenous sugar receptors, as part of an intercellular information code system, may represent a further way of studying the mechanism of tumor differentiation and propagation.
细胞糖缀合物(糖蛋白、蛋白聚糖、糖脂和蛋白聚糖)的碳水化合物部分以及特定的内源性糖受体,即凝集素,可以在细胞和亚细胞水平上基于蛋白质 - 糖相互作用建立一个生物识别系统。为了深入了解蛋白质在这种相互作用中的作用,使用带有不同糖部分的生物素化新糖蛋白,对手术切除的中枢和周围神经组织肿瘤标本切片进行了糖组织化学分析。用这种类型的探针进行特异性染色,将不同的糖部分作为配体暴露出来,表明在不同类型的脑膜瘤、胶质母细胞瘤、神经节细胞瘤、间变性和高分化少突胶质细胞瘤以及室管膜瘤中,以及在周围神经的神经鞘瘤和神经纤维瘤中存在糖受体。与高分化室管膜瘤相比,这种肿瘤的间变形式表现出普遍更高的特异性结合含有α - 或β - 葡萄糖苷的新糖蛋白的能力。当将间变性和分化型少突胶质细胞瘤相互比较时,分别观察到与6 - 磷酸半乳糖、β(1.3) - N - 乙酰半乳糖胺 - N - 乙酰 - D - 葡萄糖胺和甘露糖(牛血清白蛋白 - 生物素)的糖组织化学反应强度相反。肿瘤去分化的神经元,即在神经节细胞瘤中,与正常大脑皮质的神经元相比,显示出内源性糖受体谱的改变。在脑膜瘤的不同亚型之间观察到糖受体的定性和定量差异。N - 乙酰 - D - 半乳糖胺受体仅存在于间变形式中,而葡萄糖醛酸特异性受体仅在脑膜皮型脑膜瘤中发现。新糖蛋白结合谱的差异表明可能存在一种称为亚恶性脑膜瘤的脑膜瘤额外亚型。内源性糖受体谱的分析可用于区分构成给定肿瘤的不同细胞群体,如在神经纤维瘤中,施万细胞和成纤维样细胞用N - 乙酰 - D - 葡萄糖胺 - (牛血清白蛋白 - 生物素)染色的情况所示。作为细胞间信息编码系统一部分的内源性糖受体表达分析,可能代表了研究肿瘤分化和增殖机制的另一种方法。